Brief: Aim Immunotech Reports Fourth Quarter Financial Results
03/04/2023 11:43
April 3 (Reuters) - AIM ImmunoTech Inc AIM.A :
* AIM IMMUNOTECH REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* AIM IMMUNOTECH - AS OF DEC 31, 2022, REPORTED CASH AND
CASH
EQUIVALENTS OF $34.2 MILLION, COMPARED TO $48.3 MILLION AS OF
DEC 31, 2021
Source text for Eikon: ID:nGNX28qCH4
Further company coverage: AIM.A
((reuters.briefs@thomsonreuters.com;))
Recent news on AIM ImmunoTech
See all newsBrief: Aim Immunotech Duripanc Primary Endpoint Analysis To Begin December 2026 Topline Results Expected Q1 2027
Brief: Aim Immunotech Files To Offer And Resell Up To 13.08 Million Shares Of Common Stock By Selling Stockholders
Brief: AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market Under NYSE American Rules
Brief: Aim Immunotech Announces Significant Increase In Stockholder Equity And Extension Of Promissory Note Maturity Date To June 2027
Brief: Aim Immunotech Announces 50% Objective Response Rate (Orr) In Upmc Recurrent Ovarian Cancer Phase 2 Clinical Trial, Suggesting Breakthrough Combination Potential